SUSAN RULE: Open Payments
NPI 1194361204 · HUTCHINSON, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,350 in 79 payments from 13 companies in 2025. Trend: 2023 $1,615 · 2024 $1,297 · 2025 $1,350
Food & beverage: $1,350
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 11 | $241 |
| Teva Pharmaceuticals USA, Inc. | 11 | $196 |
| ABBVIE INC. | 12 | $162 |
| E.R. Squibb & Sons, L.L.C. | 8 | $162 |
| Alkermes, Inc. | 12 | $159 |
| Lundbeck LLC | 5 | $86 |
| Neurocrine BioSciences, Inc. | 5 | $80 |
| Supernus Pharmaceuticals, Inc. | 5 | $71 |
| Vanda Pharmaceuticals Inc. | 2 | $65 |
| Otsuka America Pharmaceutical, Inc. | 3 | $52 |
Products named: VRAYLAR, COBENFY, SPRAVATO, ARISTADA, UZEDY, INVEGA SUSTENNA, REXULTI, INGREZZA.
Industry payments across KS — which companies pay providers there.
